Navigation Links
Study Published in Journal of Vascular Surgery Confirms Superiority of Artegraft BCA to Cuffed ePTFE for Hemodialysis Access
Date:7/20/2011

NORTH BRUNSWICK, N.J., July 20, 2011 /PRNewswire/ -- Artegraft, Inc. announces that a three-year prospective, randomized clinical study published in the June 2011 issue of the Journal of Vascular Surgery confirms the superiority of Artegraft® Bovine Carotid Artery vascular grafts (BCA) to cuffed ePTFE grafts. Conducted at Massachusetts General Hospital, the study concluded that the BCA graft had significantly higher primary and assisted patency rates than the ePTFE graft, making Artegraft an excellent option for patients on hemodialysis who are not eligible for native arteriovenous fistulas.

The study results concluded that the Overall Primary Patency Rate at one year was 60 percent for Artegraft and 10 percent for ePTFE. For Assisted Primary Patency Rate at one year, Artegraft was 60 percent and ePTFE was 20 percent, according to the study results. After two years, the Assisted Primary Rate was 40 percent for Artegraft and 14 percent for ePTFE. Study results also concluded that there were less thrombosis and fewer interventions with the Artegraft BCA, as well as no pseudoaneurysms.

"The study validates the results that leading surgeons who have used Artegraft have experienced for 40 years," said Richard A. Gibson, President and Chief Executive Officer, Artegraft. "Our BCA grafts have been successfully used in thousands of patients. Its success is due to many factors, including the superior placement characteristics of Artegraft and that it is naturally accepted by the body."

A natural collagen vascular graft, Artegraft is processed to enhance long-term patency and
provide a tightly woven, cross-linked conduit that is flexible and compliant. It is especially ideal to utilize in patients with failed or immature native fistula; interposition in a fistula with a ruptured aneurysm; groin access; low protein conditions in which seroma formation may occur; and patients with hypotension. Patients suffering from an infected ePTFE graft or recurrent clotting with a synthetic graft or fistula are candidates for Artegraft, as well.

About Artegraft

Incorporated in 1993, Artegraft Inc. offers surgeons a biological alternative to synthetic grafts.  Artegraft's natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft is also positioned as an alternative to a non-viable autogenous fistula. Artegraft was the first vascular graft approved by the FDA in 1970 and has been in continuous clinical use for over 35 years. 

For more information, visit www.artegraft.com


'/>"/>
SOURCE Artegraft, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
2. Upsher-Smith Laboratories Begins Phase III Study of Intranasal Midazolam for Rescue Treatment of Seizure Clusters in Epilepsy Patients
3. Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners
4. Study Confirms that OrbusNeichs Genous™ Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity
5. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
6. Exenatide tQT Study Showed No Prolongation of QT Interval
7. PicoCal Inc. Announces Completion of NSF Funded Research With a Number of New Products, Patents, Publications of Innovative Devices for Topographical Imaging, Thermomechanical Analysis, the Study of Local Mechanical Properties and High Throughput Ap
8. Edward Breast Imaging Expert Lauds Swedish Mammography Study
9. Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare
10. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
11. Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytrens Contracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... 19, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... on Friday, July 28, 2017, beginning at 7:30 a.m. (CDT) ... Dial-in information: To participate in the conference call, dial (877) ... call at least 10 minutes prior to the start to ... Webcast: A simultaneous webcast ...
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/12/2017)... June 12, 2017 Kineta, Inc., a biotechnology company ... Kineta Vice President of R&D and Head of Virology ... Pandemic Preparedness for the Northwest and Beyond meeting sponsored ... June 14, 2017 from 8:30-10:30 AM PDT at the Agora ... Dr. Bedard will be joined by other leaders ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... Antoine Dental Center is now offering various types of ... and act as a support for prosthetic teeth, such as crowns, bridges, or dentures. An ... becomes a sturdy, lasting new root for the tooth. , Several types of dental ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... the country, today announced the hiring of Richard Robinson as chief operating officer ... and operations experience, with a proven track record of simplifying business processes and ...
(Date:6/26/2017)... ... June 26, 2017 , ... A new and improved ... women look and feel about themselves and their sexual encounters. A unique medical ... urinary leakage head on with a ground breaking medical technique aimed to give ...
(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/26/2017)... WI (PRWEB) , ... June 26, 2017 , ... New ... consultations from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a ... benefits of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, ...
Breaking Medicine News(10 mins):